Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

1,2-benzisothiazol-3(2H)-one, 2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-, 1,1-dioxide MeSH Supplementary Concept Data 2025


MeSH Supplementary
1,2-benzisothiazol-3(2H)-one, 2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-, 1,1-dioxide
Unique ID
C106973
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C106973
Entry Term(s)
2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-1,2-benzisothiazol-3(2H)-one-1,1-dioxide
DU 125530
DU-125530
Registry Numbers
ZB05V621UD
0
Heading Mapped to
*Piperazines
*Thiazoles
Frequency
5
Note
5-HT(1A) receptor antagonist; structure in first source
Source
Eur J Pharmacol 1997 May 1;325(2-3):145-53
Date of Entry
1997/07/31
Revision Date
2012/11/05
1,2-benzisothiazol-3(2H)-one, 2-(4-(4-(7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl)butyl)-, 1,1-dioxide Preferred
DU 125530 Narrower
page delivered in 0.006s